Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivi...
Quetiapine is used in the symptomatic treatment of schizophrenia. In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in comb...
Clinic for psychiatry, psychotherapy and psychosomatic, RWTH Aachen University Hospital, Aachen, NRW, Germany
Bezirkskrankenhaus Augsburg, Augsburg, Germany
Krankenhaus Hedwigshöhe, Berlin, Germany
Hannover Medical School, Hannover, Germany
Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Munich, Bavaria, Germany
University Hospital Marques de Valdecilla, Santander, Cantabria, Spain
Beijing HuiLongGuan Hospital, Beijing, China
the Second Xiangya Hospital, Changsha, Hunan, China
Columbia University Medical Center, New York, New York, United States
NY Prebyterian Hospital/Weill Cornell Medical Center, New York, New York, United States
Dept. of Pharmacology, University of Cologne, Cologne, NRW, Germany
Central Institute of Mental Health, Mannheim, BW, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.